1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid

C26H24N6O3 — CID 163290264

IUPAC1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid
SMILESNc1ncc(CN2CCc3cc(-c4ccc5c(=O)c(C(=O)O)cn(C6CC6)c5c4)ccc32)c(N)n1
InChIInChI=1S/C26H24N6O3/c27-24-17(11-29-26(28)30-24)12-31-8-7-16-9-14(2-6-21(16)31)15-1-5-19-22(10-15)32(18-3-4-18)13-20(23(19)33)25(34)35/h1-2,5-6,9-11,13,18H,3-4,7-8,12H2,(H,34,35)(H4,27,28,29,30)
InChIKeyZTKAXUPQSLPOBE-UHFFFAOYSA-N
MW468.52 g/mol
LogP3.22
Rot. Bonds5

About 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid

1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid (PubChem CID 163290264) has the molecular formula C26H24N6O3 and a molecular weight of 468.52 g/mol. Its IUPAC name is 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid.

Molecular Properties

Compound Name1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid
PubChem CID163290264
Molecular FormulaC26H24N6O3
Molecular Weight468.52 g/mol
Exact Mass468.19
IUPAC Name1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid
SMILESNc1ncc(CN2CCc3cc(-c4ccc5c(=O)c(C(=O)O)cn(C6CC6)c5c4)ccc32)c(N)n1
InChIInChI=1S/C26H24N6O3/c27-24-17(11-29-26(28)30-24)12-31-8-7-16-9-14(2-6-21(16)31)15-1-5-19-22(10-15)32(18-3-4-18)13-20(23(19)33)25(34)35/h1-2,5-6,9-11,13,18H,3-4,7-8,12H2,(H,34,35)(H4,27,28,29,30)
InChIKeyZTKAXUPQSLPOBE-UHFFFAOYSA-N
XLogP3.22
TPSA140.36 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500468.52
LogP ≤ 53.22
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid?
The IUPAC name of 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid (CID 163290264) is 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid.
What is the SMILES notation for 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid?
The canonical SMILES for 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid is Nc1ncc(CN2CCc3cc(-c4ccc5c(=O)c(C(=O)O)cn(C6CC6)c5c4)ccc32)c(N)n1.
What is the InChIKey of 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid?
The InChIKey is ZTKAXUPQSLPOBE-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24N6O3/c27-24-17(11-29-26(28)30-24)12-31-8-7-16-9-14(2-6-21(16)31)15-1-5-19-22(10-15)32(18-3-4-18)13-20(23(19)33)25(34)35/h1-2,5-6,9-11,13,18H,3-4,7-8,12H2,(H,34,35)(H4,27,28,29,30).
What are the key properties of 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid?
1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid has a molecular weight of 468.52 g/mol, XLogP of 3.22, 5 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclopropyl-7-[1-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dihydroindol-5-yl]-4-oxoquinoline-3-carboxylic acid is sourced from PubChem (CID 163290264), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).